The mutational profile of CRC tumors, including KRAS, NRAS, BRAF, PIK3CA, and AKT1 gene mutation and MSI status significantly influences the characteristics of the tumor microenvironment (TME) and directly impacts patient prognosis. The gene discussed is BRAF; the disease is colorectal carcinoma.